PFD Capital Partners is pleased to share a featured video interview of Dr. Christopher Duma, CEO of Regeneration Biomedical, on the highly regarded Life Sciences Success podcast hosted by Dr. Don Davis. In the episode, Dr. Duma provides valuable insight into the limitations of current treatment options for central nervous system (CNS) diseases such as Alzheimer’s and Parkinson’s. He explains how Regeneration Biomedical’s innovative stem cell delivery technology—administered via an intracerebroventricular (ICV) approach—has the potential to significantly improve patient outcomes by targeting the brain more directly and effectively than traditional methods.

Regeneration Biomedical is a cornerstone company in PFD’s upcoming PFDSMRH3002 Special Purpose Entity (SPE), a unique offering that builds upon PFD’s proven track record in medical receivable financing within the personal injury space. Through this SPE, investors now have the added opportunity to gain equity exposure in a cutting-edge medical technology company that PFD has thoroughly vetted and identified as having high-growth potential. The interview not only highlights the clinical promise of Regeneration Biomedical’s technology, but also reinforces the strategic vision behind PFDSMRH3002 as a hybrid vehicle for both income generation and long-term equity appreciation in the life sciences sector.